Skip to main content

. 1961 Mar;15(1):85–100. doi: 10.1038/bjc.1961.10

Carcinogenic Activity of a Series of Reactive Lactones and Related Substances

F Dickens, H E H Jones

PMCID: PMC2071115 PMID: 13722681

Images in this article

Figs. 5-6
on p.92-5

Figs. 3-4
on p.92-3

Figs. 1-2
on p.92-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BARSON G. J., CRAWFORD N., RAINS A. J., SHARPE S. H., SHREWSBURY J. F. Management of an artery-graft bank; with special reference to sterilisation by beta-propiolactone. Lancet. 1956 Oct 20;271(6947):830–832. [PubMed] [Google Scholar]
BERNHEIM F., GALE G. R. Effect of beta-propiolactone on metabolism of pseudomonas aeruginosa and growth of certain fungi. Proc Soc Exp Biol Med. 1952 May;80(1):162–164. doi: 10.3181/00379727-80-19556. [DOI] [PubMed] [Google Scholar]
Birkinshaw J. H., Oxford A. E., Raistrick H. Studies in the biochemistry of micro-organisms: Penicillic acid, a metabolic product of Penicillium puberulum Bainier and P. cylopium Westling. Biochem J. 1936 Mar;30(3):394–411. doi: 10.1042/bj0300394. [DOI] [PMC free article] [PubMed] [Google Scholar]
ELAM J. F., GEE L. L., COUCH J. R. Effect of feeding penicillin on the life cycle of the chick. Proc Soc Exp Biol Med. 1951 Jun;77(2):209–213. doi: 10.3181/00379727-77-18726. [DOI] [PubMed] [Google Scholar]
ENGELBRETH-HOLM J., ROHOLT K. Investigations into the toxicity of benzylpenicillin-beta-diethylaminoethyl ester. Acta Pharmacol Toxicol (Copenh) 1953;9(2):117–124. [PubMed] [Google Scholar]
GALE G. R. The effect of beta-propiolactone on the metabolism of Blastomyces dermatitidis. J Bacteriol. 1953 May;65(5):505–508. doi: 10.1128/jb.65.5.505-508.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
GILLMAN J., GILBERT C., SPENCE I. Phaeochromocytoma in the rat; pathogenesis and collateral reactions and its relation to comparable tumours in man. Cancer. 1953 May;6(3):494–511. doi: 10.1002/1097-0142(195305)6:3<494::aid-cncr2820060308>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
GLENDENNING O. M., ROE F. J. The carcinogenicity of beta-propiolactone for mouseskin. Br J Cancer. 1956 Jun;10(2):357–362. doi: 10.1038/bjc.1956.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hauschka T., Toennies G., Swain A. P. THE MECHANISM OF GROWTH INHIBITION BY HEXENOLACTONE. Science. 1945 Apr 13;101(2624):383–385. doi: 10.1126/science.101.2624.383-a. [DOI] [PubMed] [Google Scholar]
KENNAWAY E. The statistical significance of biological data. Br Med J. 1954 Sep 18;2(4889):663–663. doi: 10.1136/bmj.2.4889.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
LINDSAY S., POTTER G. D., CHAIKOFF I. L. Thyroid neoplasms in the rat: a comparison of naturally occurring and I131-induced tumors. Cancer Res. 1957 Apr;17(3):183–189. [PubMed] [Google Scholar]
NAKKEN K. F., ELDJARN L., PIHL A. The mechanism of inactivation of penicillin by cysteine and other mercaptoamines. Biochem Pharmacol. 1960 May;3:89–100. doi: 10.1016/0006-2952(60)90025-3. [DOI] [PubMed] [Google Scholar]
SMITH H. H., SRB A. M. Induction of mutations with beta-propiolactone. Science. 1951 Nov 9;114(2967):490–492. doi: 10.1126/science.114.2967.490. [DOI] [PubMed] [Google Scholar]
WALPOLE A. L., ROBERTS D. C., ROSE F. L., HENDRY J. A., HOMER R. F. Cytotoxic agents. IV. The carcinogenic actions of some monofunctional ethyleneimine derivatives. Br J Pharmacol Chemother. 1954 Sep;9(3):306–323. doi: 10.1111/j.1476-5381.1954.tb01686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES